First-in-human pharmacokinetic, safety, and preliminary efficacy of single- and multiple-dose FRSW117, a novel PEGylated recombinant factor VIII-Fc fusion protein with an extended half-life, in patients with severe hemophilia AFeng Xue, Renchi Yang, Ping Liu et al.|Haematologica|2025Cited by 0